A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Indivi AG
- Study ID
- NCT07174869
- Status
- Recruiting
Conditions
- Mild Alzheimer Disease
- Mild Cognitive Impairment (MCI)
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 90 Years
- Healthy Volunteers
- Accepted
Study Details
The goal of this observational study is to evaluate the functionality and usability of Indivi mobile application-based cognitive activities in people with mild cognitive impairment/mild Alzheimer's disease (PwMCI/AD) and healthy controls (HC). This application uses a dynamic difficulty adjustment (DDA) system that customizes the level of the cognitive activities to each user. The main questions it aims to answer are: * Does the DDA system reach a stable difficulty level at the same rate for both PwMCI/AD and HC? * Is the stable difficulty level reached by the DDA system different for PwMCI/AD compared to HC? Researchers will also compare cognitive activities results and other aspects of the mobile application's performance to see if the application can validly distinguish between the two groups. Participants will use the Indivi mobile application, with its embedded DDA system, for a 6-week period.
Key Dates
- Start date
- Sep 30, 2025
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 55 participants (estimated)
Arms
- Arm: PwMCI/ADPersons with Mild Cognitive Impairment or mild Alzheimer's Disease
- Arm: HCHealthy Controls
Primary Outcome Measure
Number of test iterations until stable difficulty level is reached [ Time Frame: During the 6-week study period. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston University School of Medicine | Boston | Massachusetts | 02118 |
Find similar trials in Boston, MA
Related Studies
- Treating Insomnia in Mild Cognitive ImpairmentRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Mindfulness for Cognition in Early-stage Alzheimer's DiseaseRecruiting · VA Boston Healthcare System · Boston, Massachusetts
- Biomarker-based Trial of NPC-1 for Alzheimer's PathologyPHASE2 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Genetic Studies of Early-onset DementiaRecruiting · Columbia University · New York, New York